[Cognitive deficits in Parkinson's disease].

PubWeight™: 0.78‹?›

🔗 View Article (PMID 1853032)

Published in Rev Neurol (Paris) on January 01, 1991

Authors

A Guillard1, G Fénelon, F Mahieux

Author Affiliations

1: Clinique Neurologique, Hôpital Tenon, Paris.

Articles citing this

Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.75

Articles by these authors

Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke (1993) 2.71

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain (2000) 2.23

Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry (2008) 1.83

Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.75

Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet (1998) 1.57

Pyramidal tract signs and Parkinson's disease. Lancet (1992) 1.41

The primate motor thalamus. Brain Res Brain Res Rev (1996) 1.33

Axial motor disturbances after hypoxic lesions of the globus pallidus. Mov Disord (1993) 1.08

A prospective study of patients with CT detected pallidal calcifications. J Neurol Neurosurg Psychiatry (1993) 1.05

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol (1995) 1.00

Topographic distribution of the axonal endings from the sensorimotor and associative striatum in the macaque pallidum and substantia nigra. Exp Brain Res (1994) 0.94

Low-frequency repetitive TMS of premotor cortex can reduce painful axial spasms in generalized secondary dystonia: a pilot study of three patients. Neurophysiol Clin (2004) 0.94

Increased plasma neurotensin concentrations in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 0.93

Munchausen's syndrome and abnormalities on magnetic resonance imaging of the brain. BMJ (1991) 0.90

[Spinal dural arteriovenous fistulae: exacerbation after myelography with metrizamide]. Rev Neurol (Paris) (1988) 0.89

[Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration?]. Rev Neurol (Paris) (2007) 0.88

AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med (1995) 0.87

Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. Report of four cases. J Neurol (1989) 0.86

[Informational analysis of the basal ganglia related system]. Rev Neurol (Paris) (1995) 0.80

[The Alice in Wonderland syndrome: an unusual aura in migraine]. Rev Neurol (Paris) (2012) 0.79

Efficacy and safety of rilmenidine for arterial hypertension. Am J Cardiol (1988) 0.79

The role of the medial pallidum in the pathophysiology of akinesia in primates. Adv Neurol (1993) 0.79

[Neuropsychological testing of 5 patients with Parkinson's disease before and after neuron graft]. Rev Neurol (Paris) (1996) 0.78

[Spinal cord compression secondary to extramedullary hematopoiesis in a patient with thalassemia]. Rev Neurol (Paris) (2000) 0.78

[History of the basal ganglia system. Slow development of a major cerebral system]. Rev Neurol (Paris) (1995) 0.78

Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin. Mov Disord (1993) 0.78

[Parkinsonian features of Steele-Richardson-Olszewski syndrome]. Rev Neurol (Paris) (1993) 0.77

[Hallucinations and dementia. Prevalence, clinical presentation and pathophysiology]. Rev Neurol (Paris) (2004) 0.77

[Memory clinics: long-term follow-up]. Therapie (1998) 0.77

Intracranial hemorrhage associated with cocaine abuse. Neurology (1998) 0.77

[Isolated meningoencephalitis in Lyme disease]. Ann Med Interne (Paris) (1987) 0.76

Apolipoprotein E4: phenotype in patients with Alzheimer's disease. Ann Neurol (1994) 0.76

Balint's syndrome. Neurology (1995) 0.75

Cerebral toxoplasmosis and movement disorders. Mov Disord (1994) 0.75

Revision of the international classification of diseases. Mov Disord (1997) 0.75

Warfarin in Sneddon's syndrome. Neurology (1996) 0.75

[Cerebral cysticercosis: 4 cases]. Ann Med Interne (Paris) (1987) 0.75

[Hypoprothrombinemia under cefotaxime during a vitamin K-deficient diet]. Presse Med (1988) 0.75

Ischaemic myelopathy secondary to disseminated intravascular coagulation in AIDS. J Neurol (1991) 0.75

[Lobar holoprosencephaly associated with heterotopic gray matter. A case disclosed in adulthood by epilepsy]. Rev Neurol (Paris) (1990) 0.75

[Recurrent acute dyskinesia as the sole manifestation of phenytoin poisoning]. Rev Neurol (Paris) (1987) 0.75

[Informational neuro-morphology of the cortico-ponto-cerebello-thalamo-cortical system in primates (compared with basal ganglia system)]. Rev Neurol (Paris) (1993) 0.75

[Polyneuritis, convulsive crises, and cerebellar syndrome, complications of treatment with metronidazole]. Presse Med (1985) 0.75

[Increase of serum procalcitonin levels during a neuroleptic malignant syndrome]. Ann Biol Clin (Paris) (2009) 0.75

[Parkinson disease: unusual treatments and perspectives]. Soins (1993) 0.75

[Cerebral amyloid angiopathy. 2 anatomoclinical cases]. Arch Anat Cytol Pathol (1986) 0.75

[Epilepsy, cerebral calcifications and celiac disease]. Rev Neurol (Paris) (1997) 0.75

[Guidelines for Alzheimer’s disease: the position of the French Neurological Society]. Rev Neurol (Paris) (2011) 0.75

[Conference at the Salpêtrière. February 1988. Muscular weakness and respiratory distress in a 40-year-old woman]. Rev Neurol (Paris) (1990) 0.75

[Meeting of consultations of memory. 1 February 1997 Paris]. Therapie (1998) 0.75

Changes in quality of life, burden and mood among spouses of Parkinson's disease patients receiving neurostimulation. Parkinsonism Relat Disord (2011) 0.75

[Peripheral neuropathy related to benign monoclonal gammopathy. Treatment with high-dose intravenous human immunoglobins]. Ann Med Interne (Paris) (1993) 0.75

[Primary central nervous system lymphoma presenting with central neurogenic hyperventilation. A case report and review of the literature]. Rev Neurol (Paris) (2005) 0.75

[Münchausen's syndrome in HTLV infected patients]. Presse Med (1987) 0.75

[Iatrogenic complications with a neuroleptic during an attack of dementia]. Presse Med (2004) 0.75

[Hallucinations. Diagnostic orientation]. Rev Prat (2000) 0.75